Technical support for governments and private manufacturers is needed to improve manufacturing quality, registration procedures, and post-marketing safety monitoring to identify manufacturing, supply chain management, and storage conditions, which expose the public to potential harm.
Some scientists may enjoy the rare opportunity to participate in a complete drug development cycle, from R&D to scale-up, manufacturing, product registration, marketing, and sales.
Accomplishing such tasks would likely be most efficient with active collaboration between Gilead and ViiV, although generic companies could take on these roles if given access to the necessary data and if they were confident enough in a return on investment to make the necessary upfront investments in formulation, manufacturing, and registration.
However, more must be done to improve the manufacturing practices and registration of drugs, so that poor-quality drugs (albeit approved by a regulatory authority) do not reach the market.
Armed with a 3D printer and the desired design and filament, an individual can print a fully functioning weapon, bypassing federal and state licensing, registration, and manufacturing requirements.
This may occur, for example, during the construction or equipping of manufacturing facilities, during drug registration or certification, during quality-control checks, including drug testing and site inspections, and during drug procurement 187– 187.
However, the MPC said growth was likely to slow modestly in the second half of the year, highlighting weaker recent data on exports, car registrations, and manufacturing.
The key to the success of surgical navigation based on computer-aided design and computer-aided manufacturing (CAD/CAM) planning is the registration process.
These novel drugs are effectively marketed "designer drugs" (also called "research chemicals") without any knowledge of the underlying pharmacology, the potential harm or a registration of the manufacturing process.
In addition to these investments in research, well-coordinated support is needed to address bottlenecks across the value chain to introduction of new ARV products, including registration, financing, marketing, manufacturing, and global and country-level policy and planning issues.
